Target intelligence / Profile preview

RNA metabolism enzymes and RNA processing machinery

Molecular classification
Enzyme, RNA-binding protein, Ribonucleoprotein complex, Transcription factor
01

Overview

RNA metabolism enzymes and RNA processing machinery represent a broad class of proteins involved in the synthesis, modification, and degradation of RNA (Nature Reviews Molecular Cell Biology, 2018). This machinery includes RNA polymerases, the spliceosome, RNA helicases, and various exonucleases that ensure the fidelity and regulation of the transcriptome (Cell, 2020). Dysregulation of these processes is a hallmark of several diseases; for instance, mutations in spliceosomal components like SF3B1 are frequent in myeloid leukemias, while defects in RNA-binding proteins are linked to neurodegenerative conditions such as Amyotrophic Lateral Sclerosis (ALS) (Nature Reviews Cancer, 2021; Neuron, 2017). Therapeutic intervention in this space has seen significant success with the development of splicing modifiers like Risdiplam for Spinal Muscular Atrophy and RNA polymerase inhibitors for viral infections (New England Journal of Medicine, 2020). However, because these enzymes are often essential for general cell survival, achieving a therapeutic window without causing global transcriptomic disruption remains a primary challenge in drug development (Trends in Pharmacological Sciences, 2019). The field is currently expanding toward targeting specific RNA-protein interactions and utilizing antisense oligonucleotides to correct processing errors in rare genetic diseases.

Other names
RNA processing factorsRNA metabolic machineryRNA-binding proteins (RBPs)Spliceosome componentsRNA-modifying enzymes
02

Mechanism of action

Modulation of pre-mRNA splicing, inhibition of RNA-dependent RNA polymerase (RdRp), inhibition of DNA-directed RNA polymerase, and interference with RNA processing and stability.

03

Biological functions

RNA splicingRNA cappingPolyadenylationRNA degradationRNA transportTranscriptionTranslation regulation
04

Disease associations

CancerNeurodegenerative diseaseViral infectionGenetic disordersSpinal muscular atrophy (SMA)Myelodysplastic syndrome (MDS)
05

Safety considerations

Global transcriptomic disruptionOff-target splicing effectsCytotoxicity in high-turnover tissuesPotential for secondary malignanciesImmunogenicity of oligonucleotide therapeutics
06

Interacting drugs

Risdiplam

7 more in the full profile.

07

Biomarkers

SMN2 exon 7 inclusion levelsSF3B1 mutation statusU2AF1 mutation statusRNA splicing patternsCirculating tumor RNA (ctRNA)

Beyond the preview

Go deeper on RNA metabolism enzymes and RNA processing machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA metabolism enzymes and RNA processing machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call